{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T08:04:00Z","timestamp":1788595440967,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China project","doi-asserted-by":"crossref","award":["81873988"],"award-info":[{"award-number":["81873988"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Key Research and Development Program of Hunan Province of China","award":["2021SK2005"],"award-info":[{"award-number":["2021SK2005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Perioperative administration of tranexamic acid (TXA) is thought to be related to decreased postoperative implant-associated infection rates; however, the relationship remains unclear. We explored the inhibitory effect of TXA on infection both in vitro and in vivo. We investigated biofilm formation after TXA administration through different detection methods, all of which showed that TXA reduces biofilm formation in vitro and was further proven to be associated with decreased protein and polysaccharide contents in biofilms. We observed decreased biofilm on implants and decreased bacteria in the infection area with strengthened neutrophil accumulation in the mouse implant-associated infection model. Our results suggest that TXA protects against implant-associated infection by reducing biofilm formation in infected tissues.<\/jats:p>","DOI":"10.1038\/s41598-022-08948-w","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T11:03:15Z","timestamp":1647946995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Tranexamic acid protects against implant-associated infection by reducing biofilm formation"],"prefix":"10.1038","volume":"12","author":[{"given":"Jiahao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tailai","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihe","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"8948_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2020.102228","volume":"283","author":"U Filipovic","year":"2020","unstructured":"Filipovic, U. et al. Bacterial adhesion on orthopedic implants. Adv. Colloid Interface Sci. 283, 102228. https:\/\/doi.org\/10.1016\/j.cis.2020.102228 (2020).","journal-title":"Adv. Colloid Interface Sci."},{"issue":"10016","key":"8948_CR2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0140-6736(14)61798-0","volume":"387","author":"BH Kapadia","year":"2016","unstructured":"Kapadia, B. H. et al. Periprosthetic joint infection. Lancet 387(10016), 386\u2013394. https:\/\/doi.org\/10.1016\/S0140-6736(14)61798-0 (2016).","journal-title":"Lancet"},{"issue":"5418","key":"8948_CR3","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","volume":"284","author":"JW Costerton","year":"1999","unstructured":"Costerton, J. W. et al. Bacterial biofilms: A common cause of persistent infections. Science 284(5418), 1318\u20131322. https:\/\/doi.org\/10.1126\/science.284.5418.1318 (1999).","journal-title":"Science"},{"issue":"9","key":"8948_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrmicro2415","volume":"8","author":"HC Flemming","year":"2010","unstructured":"Flemming, H. C. & Wingender, J. The biofilm matrix. Nat. Rev. Microbiol. 8(9), 623\u2013633. https:\/\/doi.org\/10.1038\/nrmicro2415 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"8948_CR5","doi-asserted-by":"publisher","unstructured":"Jiang, Y., et al. (2020). Targeting biofilms therapy: Current research strategies and development hurdles. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms8081222","DOI":"10.3390\/microorganisms8081222"},{"issue":"9734","key":"8948_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","volume":"376","author":"H Shakur","year":"2010","unstructured":"Shakur, H. et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 376(9734), 23\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(10)60835-5 (2010).","journal-title":"Lancet"},{"issue":"10","key":"8948_CR7","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1016\/j.arth.2018.03.031","volume":"33","author":"YA Fillingham","year":"2018","unstructured":"Fillingham, Y. A. et al. The safety of tranexamic acid in total joint arthroplasty: A direct meta-analysis. J. Arthroplasty 33(10), 3070\u20133082. https:\/\/doi.org\/10.1016\/j.arth.2018.03.031 (2018).","journal-title":"J. Arthroplasty"},{"issue":"3","key":"8948_CR8","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.arth.2020.10.003","volume":"36","author":"GJ Hong","year":"2021","unstructured":"Hong, G. J. et al. Tranexamic acid administration is associated with a decreased odds of prosthetic joint infection following primary total hip and primary total knee arthroplasty: A national database analysis. J. Arthroplasty 36(3), 1109\u20131113. https:\/\/doi.org\/10.1016\/j.arth.2020.10.003 (2021).","journal-title":"J. Arthroplasty"},{"issue":"15","key":"8948_CR9","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.2106\/JBJS.19.00925","volume":"102","author":"MR Klement","year":"2020","unstructured":"Klement, M. R. et al. Tranexamic acid reduces the rate of periprosthetic joint infection after aseptic revision arthroplasty. J. Bone Joint Surg. Am. 102(15), 1344\u20131350. https:\/\/doi.org\/10.2106\/JBJS.19.00925 (2020).","journal-title":"J. Bone Joint Surg. Am."},{"issue":"3","key":"8948_CR10","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.arth.2019.10.029","volume":"35","author":"H Yazdi","year":"2020","unstructured":"Yazdi, H. et al. Tranexamic acid is associated with reduced periprosthetic joint infection after primary total joint arthroplasty. J. Arthroplasty 35(3), 840\u2013844. https:\/\/doi.org\/10.1016\/j.arth.2019.10.029 (2020).","journal-title":"J. Arthroplasty"},{"issue":"2","key":"8948_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.7150\/jbji.25610","volume":"3","author":"S Mannan","year":"2018","unstructured":"Mannan, S. et al. The use of tranexamic acid in total elbow replacement to reduce post-operative wound infection. J. Bone Jt. Infect. 3(2), 104\u2013107. https:\/\/doi.org\/10.7150\/jbji.25610 (2018).","journal-title":"J. Bone Jt. Infect."},{"key":"8948_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5748069","author":"FY Zhang","year":"2021","unstructured":"Zhang, F. Y. et al. The topical tranexamic acid have potential hazard of promoting biofilm formation of Staphylococcus aureus in microenvironment of the prosthetic joint. Biomed. Res. Int. https:\/\/doi.org\/10.1155\/2021\/5748069 (2021).","journal-title":"Biomed. Res. Int."},{"key":"8948_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00026-19","author":"K Schilcher","year":"2020","unstructured":"Schilcher, K. & Horswill, A. R. Staphylococcal biofilm development: Structure, regulation, and treatment strategies. Microbiol. Mol. Biol. Rev. https:\/\/doi.org\/10.1128\/MMBR.00026-19 (2020).","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"1","key":"8948_CR14","doi-asserted-by":"publisher","first-page":"6157","DOI":"10.1038\/s41467-021-26244-5","volume":"12","author":"JAE Payne","year":"2021","unstructured":"Payne, J. A. E. et al. Antibiotic-chemoattractants enhance neutrophil clearance of Staphylococcus aureus. Nat. Commun. 12(1), 6157. https:\/\/doi.org\/10.1038\/s41467-021-26244-5 (2021).","journal-title":"Nat. Commun."},{"issue":"10","key":"8948_CR15","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1016\/j.arth.2018.06.023","volume":"33","author":"YA Fillingham","year":"2018","unstructured":"Fillingham, Y. A. et al. The efficacy of tranexamic acid in total hip arthroplasty: A network meta-analysis. J. Arthroplasty 33(10), 3083\u20133089. https:\/\/doi.org\/10.1016\/j.arth.2018.06.023 (2018).","journal-title":"J. Arthroplasty"},{"issue":"10","key":"8948_CR16","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1016\/j.arth.2018.04.043","volume":"33","author":"YA Fillingham","year":"2018","unstructured":"Fillingham, Y. A. et al. The efficacy of tranexamic acid in total knee arthroplasty: A network meta-analysis. J. Arthroplasty 33(10), 3090\u20133098. https:\/\/doi.org\/10.1016\/j.arth.2018.04.043 (2018).","journal-title":"J. Arthroplasty"},{"issue":"1","key":"8948_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/rapm-2018-000024","volume":"44","author":"YA Fillingham","year":"2019","unstructured":"Fillingham, Y. A. et al. Tranexamic acid in total joint arthroplasty: The endorsed clinical practice guides of the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society. Reg. Anesth. Pain Med. 44(1), 7\u201311. https:\/\/doi.org\/10.1136\/rapm-2018-000024 (2019).","journal-title":"Reg. Anesth. Pain Med."},{"key":"8948_CR18","unstructured":"DrugBank. (2016). Tranexamic acid. https:\/\/go.drugbank.com\/drugs\/DB00302 [Accessed August 12, 2021]."},{"issue":"2","key":"8948_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41589-019-0401-8","volume":"16","author":"OM El-Halfawy","year":"2020","unstructured":"El-Halfawy, O. M. et al. Discovery of an antivirulence compound that reverses \u03b2-lactam resistance in MRSA. Nat. Chem. Biol. 16(2), 143\u2013149. https:\/\/doi.org\/10.1038\/s41589-019-0401-8 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"8948_CR20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.actbio.2016.11.061","volume":"49","author":"B Mishra","year":"2017","unstructured":"Mishra, B. et al. Design and surface immobilization of short anti-biofilm peptides. Acta Biomater. 49, 316\u2013328. https:\/\/doi.org\/10.1016\/j.actbio.2016.11.061 (2017).","journal-title":"Acta Biomater."},{"issue":"1","key":"8948_CR21","doi-asserted-by":"publisher","first-page":"20243","DOI":"10.1038\/s41598-019-56627-0","volume":"9","author":"L Shi","year":"2019","unstructured":"Shi, L. et al. Effect of nicotine on Staphylococcus aureus biofilm formation and virulence factors. Sci. Rep. 9(1), 20243. https:\/\/doi.org\/10.1038\/s41598-019-56627-0 (2019).","journal-title":"Sci. Rep."},{"issue":"11","key":"8948_CR22","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.jsps.2020.09.002","volume":"28","author":"P Alam","year":"2020","unstructured":"Alam, P. et al. Siphonocholin isolated from red sea sponge Siphonochalina siphonella attenuates quorum sensing controlled virulence and biofilm formation. Saudi Pharm J. 28(11), 1383\u20131391. https:\/\/doi.org\/10.1016\/j.jsps.2020.09.002 (2020).","journal-title":"Saudi Pharm J."},{"issue":"2","key":"8948_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.biomaterials.2011.09.084","volume":"33","author":"H Tan","year":"2012","unstructured":"Tan, H. et al. The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus. Biomaterials 33(2), 365\u2013377. https:\/\/doi.org\/10.1016\/j.biomaterials.2011.09.084 (2012).","journal-title":"Biomaterials"},{"key":"8948_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2019.100010","volume":"2","author":"J Allkja","year":"2020","unstructured":"Allkja, J. et al. Minimum information guideline for spectrophotometric and fluorometric methods to assess biofilm formation in microplates. Biofilm 2, 100010. https:\/\/doi.org\/10.1016\/j.bioflm.2019.100010 (2020).","journal-title":"Biofilm"},{"issue":"5","key":"8948_CR25","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.chemosphere.2010.03.043","volume":"81","author":"Z Liang","year":"2010","unstructured":"Liang, Z. et al. Extraction and structural characteristics of extracellular polymeric substances (EPS), pellets in autotrophic nitrifying biofilm and activated sludge. Chemosphere 81(5), 626\u2013632. https:\/\/doi.org\/10.1016\/j.chemosphere.2010.03.043 (2010).","journal-title":"Chemosphere"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08948-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08948-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08948-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:44:12Z","timestamp":1669337052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08948-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8948"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-08948-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"assertion":[{"value":"18 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4840"}}